{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Pneumococcal+Conjugate+Vaccine+formulation+2", "query": { "intervention": "Pneumococcal Conjugate Vaccine formulation 2" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 13, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Pneumococcal+Conjugate+Vaccine+formulation+2&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-26T00:12:23.111Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT07712575", "title": "A Study of V132 in Healthy Older Participants (V132-001)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "V132 Formulation 1", "type": "BIOLOGICAL" }, { "name": "V132 Formulation 2", "type": "BIOLOGICAL" }, { "name": "V132 Formulation 3", "type": "BIOLOGICAL" }, { "name": "PREVNAR 20™", "type": "BIOLOGICAL" }, { "name": "CAPVAXIVE™", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "50 Years to 75 Years" }, "enrollment_count": 280, "start_date": "2026-08-12", "completion_date": "2028-06-21", "has_results": false, "last_update_posted_date": "2026-09-02", "last_synced_at": "2026-09-26T00:12:23.111Z", "location_count": 9, "location_summary": "Anaheim, California • Hallandale, Florida • Hollywood, Florida + 6 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Hallandale", "state": "Florida" }, { "city": "Hollywood", "state": "Florida" }, { "city": "South Miami", "state": "Florida" }, { "city": "Springfield", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT07712575" }, { "nct_id": "NCT03207750", "title": "This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rotavirus Infection", "Rotavirus Vaccines" ], "interventions": [ { "name": "Rotarix", "type": "BIOLOGICAL" }, { "name": "Pediarix", "type": "BIOLOGICAL" }, { "name": "Hiberix", "type": "BIOLOGICAL" }, { "name": "Prevenar 13", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "12 Weeks", "sex": "ALL", "summary": "6 Weeks to 12 Weeks" }, "enrollment_count": 1280, "start_date": "2017-09-14", "completion_date": "2019-03-01", "has_results": true, "last_update_posted_date": "2020-12-29", "last_synced_at": "2026-09-26T00:12:23.111Z", "location_count": 47, "location_summary": "Birmingham, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 40 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Daly City", "state": "California" }, { "city": "Oakland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03207750" }, { "nct_id": "NCT00578175", "title": "Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Varicella", "Rubella", "Mumps", "Measles" ], "interventions": [ { "name": "Priorix-Tetra™ (MMRV vaccine 208136)", "type": "BIOLOGICAL" }, { "name": "ProQuad®", "type": "BIOLOGICAL" }, { "name": "Havrix®", "type": "BIOLOGICAL" }, { "name": "Prevnar®", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "12 Months", "maximum_age": "14 Months", "sex": "ALL", "summary": "12 Months to 14 Months" }, "enrollment_count": 1851, "start_date": "2007-11-20", "completion_date": "2009-03-17", "has_results": true, "last_update_posted_date": "2018-10-09", "last_synced_at": "2026-09-26T00:12:23.111Z", "location_count": 141, "location_summary": "Birmingham, Alabama • Tuscaloosa, Alabama • Phoenix, Arizona + 125 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Benton", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00578175" }, { "nct_id": "NCT04398706", "title": "Study of a Pneumococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Toddlers and Infants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pneumococcal Immunisation", "Diphtheria Immunisation", "Tetanus Immunisation", "Pertussis Immunisation", "Hepatitis B Immunisation", "Haemophilus Influenzae Type b Immunisation", "Polio Immunisation", "Measles Immunisation", "Rubella Immunisation", "Varicella Immunisation", "Mumps Immunisation" ], "interventions": [ { "name": "Pneumococcal Conjugate Vaccine formulation 1", "type": "BIOLOGICAL" }, { "name": "Pneumococcal Conjugate Vaccine formulation 2", "type": "BIOLOGICAL" }, { "name": "Pneumococcal Conjugate Vaccine formulation 3", "type": "BIOLOGICAL" }, { "name": "Varicella Virus Vaccine Live", "type": "BIOLOGICAL" }, { "name": "Measles, Mumps, and Rubella Virus Vaccine Live", "type": "BIOLOGICAL" }, { "name": "Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]", "type": "BIOLOGICAL" }, { "name": "Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus b Conjugate (Tetanus Toxoid Conjugate)", "type": "BIOLOGICAL" }, { "name": "Rotavirus Vaccine, Live, Oral, Pentavalent", "type": "BIOLOGICAL" }, { "name": "Hepatitis B Vaccine* [Recombinant] *as applicable", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "15 Months", "sex": "ALL", "summary": "42 Days to 15 Months" }, "enrollment_count": 852, "start_date": "2020-05-22", "completion_date": "2023-08-10", "has_results": true, "last_update_posted_date": "2025-09-08", "last_synced_at": "2026-09-26T00:12:23.111Z", "location_count": 49, "location_summary": "Jonesboro, Arkansas • Bellflower, California • Huntington Park, California + 41 more", "locations": [ { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Bellflower", "state": "California" }, { "city": "Huntington Park", "state": "California" }, { "city": "Huntington Park", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04398706" }, { "nct_id": "NCT07168915", "title": "A Study of V118E in Healthy Participants (V118E-003)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "V118E", "type": "BIOLOGICAL" }, { "name": "PREVNAR 20™", "type": "BIOLOGICAL" }, { "name": "Saline", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 126, "start_date": "2025-10-08", "completion_date": "2027-07-06", "has_results": false, "last_update_posted_date": "2026-07-15", "last_synced_at": "2026-09-26T00:12:23.111Z", "location_count": 4, "location_summary": "Hallandale, Florida • South Miami, Florida • Springfield, Missouri + 1 more", "locations": [ { "city": "Hallandale", "state": "Florida" }, { "city": "South Miami", "state": "Florida" }, { "city": "Springfield", "state": "Missouri" }, { "city": "Galveston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07168915" }, { "nct_id": "NCT03642847", "title": "Trial to Evaluate the Safety and Immunogenicity of Multivalent Pneumococcal Vaccines in Japanese Adults 18 to 49 Years of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pneumococcal Infections" ], "interventions": [ { "name": "Prevnar 13", "type": "BIOLOGICAL" }, { "name": "multivalent pneumococcal conjugate formulation 1", "type": "BIOLOGICAL" }, { "name": "multivalent pneumococcal conjugate formulation 2", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "18 Years to 49 Years" }, "enrollment_count": 104, "start_date": "2018-08-29", "completion_date": "2019-03-29", "has_results": false, "last_update_posted_date": "2019-06-12", "last_synced_at": "2026-09-26T00:12:23.111Z", "location_count": 4, "location_summary": "Garden Grove, California • Long Beach, California • Honolulu, Hawaii + 1 more", "locations": [ { "city": "Garden Grove", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Honolulu", "state": "Hawaii" }, { "city": "Eatontown", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT03642847" }, { "nct_id": "NCT06337643", "title": "A Study to Evaluate Tolerability, Safety and Immunogenicity of MVX01 Pneumococcal Vaccine", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pneumococcal Vaccine" ], "interventions": [ { "name": "MVX01", "type": "BIOLOGICAL" }, { "name": "MVX01 Placebo", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Matrivax Research and Development Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 75, "start_date": "2023-03-07", "completion_date": "2024-04-16", "has_results": false, "last_update_posted_date": "2024-03-29", "last_synced_at": "2026-09-26T00:12:23.111Z", "location_count": 2, "location_summary": "Savannah, Georgia • Knoxville, Tennessee", "locations": [ { "city": "Savannah", "state": "Georgia" }, { "city": "Knoxville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT06337643" }, { "nct_id": "NCT04583618", "title": "Study of a Pneumococcal Conjugate Vaccine in Adults Aged 50 to 84 Years.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pneumococcal Immunization" ], "interventions": [ { "name": "Pneumococcal Conjugate Vaccine - formulation 1-SP0202-IIb", "type": "BIOLOGICAL" }, { "name": "Pneumococcal Conjugate Vaccine - formulation 2-SP0202-VI", "type": "BIOLOGICAL" }, { "name": "Pneumococcal Conjugate Vaccine - formulation 3-SP0202-VII", "type": "BIOLOGICAL" }, { "name": "Pneumococcal 13 - valent conjugate vaccine-Prevnar 13", "type": "BIOLOGICAL" }, { "name": "Pneumococcal Vaccine Polyvalent-Pneumovax 23", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "84 Years", "sex": "ALL", "summary": "50 Years to 84 Years" }, "enrollment_count": 750, "start_date": "2020-10-08", "completion_date": "2022-01-20", "has_results": true, "last_update_posted_date": "2025-09-08", "last_synced_at": "2026-09-26T00:12:23.111Z", "location_count": 17, "location_summary": "Anaheim, California • Rolling Hills Estates, California • Wheat Ridge, Colorado + 14 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Rolling Hills Estates", "state": "California" }, { "city": "Wheat Ridge", "state": "Colorado" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04583618" }, { "nct_id": "NCT06698198", "title": "Safety and Immunogenicity of a Pneumococcal Conjugate Vaccine Candidate in Healthy Adults (19-49 Years)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pneumococcal Immunization" ], "interventions": [ { "name": "Pneumococcal Conjugate Vaccine", "type": "BIOLOGICAL" }, { "name": "Prevnar 13®", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "19 Years", "maximum_age": "49 Years", "sex": "ALL", "summary": "19 Years to 49 Years" }, "enrollment_count": 175, "start_date": "2018-12-03", "completion_date": "2019-09-30", "has_results": false, "last_update_posted_date": "2024-11-20", "last_synced_at": "2026-09-26T00:12:23.111Z", "location_count": 2, "location_summary": "Metairie, Louisiana • Newark, New Jersey", "locations": [ { "city": "Metairie", "state": "Louisiana" }, { "city": "Newark", "state": "New Jersey" } ], "official_url": "https://clinicaltrials.gov/study/NCT06698198" }, { "nct_id": "NCT05831124", "title": "A Study to Learn About a Type of Pneumococcal Vaccine With a New Ingredient (PF-07872411) Intended to Enhance the Effects of the Vaccine Which is Given to Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Pneumococcal Disease" ], "interventions": [ { "name": "Low dose multivalent pneumococcal conjugate vaccine formulation A", "type": "OTHER" }, { "name": "Low dose multivalent pneumococcal conjugate vaccine formulation B", "type": "OTHER" }, { "name": "Low dose of multivalent pneumococcal conjugate vaccine control", "type": "BIOLOGICAL" }, { "name": "Standard dose multivalent pneumococcal conjugate vaccine control", "type": "BIOLOGICAL" } ], "intervention_types": [ "OTHER", "BIOLOGICAL" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "50 Years", "maximum_age": "64 Years", "sex": "ALL", "summary": "50 Years to 64 Years" }, "enrollment_count": 90, "start_date": "2023-04-19", "completion_date": "2024-06-26", "has_results": false, "last_update_posted_date": "2024-07-29", "last_synced_at": "2026-09-26T00:12:23.111Z", "location_count": 9, "location_summary": "Hialeah, Florida • Hollywood, Florida • Columbia, Maryland + 4 more", "locations": [ { "city": "Hialeah", "state": "Florida" }, { "city": "Hollywood", "state": "Florida" }, { "city": "Hollywood", "state": "Florida" }, { "city": "Columbia", "state": "Maryland" }, { "city": "Elkridge", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT05831124" } ] }